The pooled result from four datasets of DFS revealed that decreased expression of PTEN was associated with unfavorable DFS in patients with NSCLC (HR = 0.57, 95% CI: 0.44–0.73, P < 0.001) (Figure 4). This evidence concerns the gene PTEN and non-small cell lung carcinoma.